Gain the insights and tools needed to proficiently manage intricate business transactions within the life sciences sector. Our comprehensive guidance supports legal practitioners in navigating mergers, acquisitions, joint ventures, and financing deals, ensuring you stay ahead in this rapidly evolving field. Whether handling due diligence or structuring agreements, access to tailored expertise can streamline your practice and enhance client outcomes.
The European Commission has published a roadmap to phase out animal testing in chemical safety assessments. In support of the initiative, the European...
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the European Commission’s roadmap towards phasing out...
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published a statement on the signature of the EU-Mexico Modernised...
The European Commission's Directorate-General for Health and Food Safety HAS announced that from 28 May 2026, the use of four modules of the European...
Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...
Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...
Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...
Priority between loss reliefs in loss making companiesWhy does it matter?A company that is a member of a group and has incurred any of the types of losses available for surrender by way of group relief may, without any further rules, have more than one way in which to use the loss. There are a
Late payment penalties—inheritance taxWhile interest often accrues on overdue tax, the late payment of certain taxes may also attract a penalty. For information on the interest accruing on overdue tax, see Practice Notes: IHT—payment deadlines on death—Interest on IHT and Interest on late paid
If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit
Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
0330 161 1234